Jindřich Rezek

Recent publications · Crossref

5 total works indexed

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

   · 2019 · cited 7,637x

2. Edoxaban versus Warfarin in Patients with Atrial Fibrillation

   · 2013 · cited 4,457x

3. Diverse Applications of Nanomedicine

   · 2017 · cited 1,209x

4. Hydrogel biomaterials: A smart future?

   · 2007 · cited 917x

5. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

   · 2019 · cited 884x

via Crossref · CC0